These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10363166

  • 1. The effect of dexamethasone on tissue fibrinolytic system in male and female rats.
    Tsantarliotou M, Taitzoglou I, Kokolis N.
    In Vivo; 1999; 13(2):119-24. PubMed ID: 10363166
    [Abstract] [Full Text] [Related]

  • 2. Circadian variations of plasminogen activator activity, tissue-type plasminogen activator antigen, plasminogen activator inhibition and plasmin inhibition in rat aorta, heart and brain are influenced by endotoxin or aspirin or endotoxin plus aspirin.
    Kokolis N, Rekkas C, Tsandarliotou M, Smokovitis A.
    Haemostasis; 1995; 25(3):106-13. PubMed ID: 7607578
    [Abstract] [Full Text] [Related]

  • 3. Variable response of tissue parameters of the fibrinolytic system to unilateral or bilateral adrenalectomy and unilateral or bilateral adrenal demedullation.
    Smokovitis A, Kokolis N, Rekkas C, Ploumis T.
    J Endocrinol Invest; 1991 Nov; 14(10):815-20. PubMed ID: 1839395
    [Abstract] [Full Text] [Related]

  • 4. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ, Boon GI, Jansen JW, Bouma BN.
    Thromb Haemost; 1993 Apr 01; 69(4):381-6. PubMed ID: 8497851
    [Abstract] [Full Text] [Related]

  • 5. Effect of growth hormone on fibrinolytic system in rat.
    Bubber P, Singh KP, Arora S, Bansal DD.
    Indian J Exp Biol; 1998 May 01; 36(5):514-6. PubMed ID: 9717468
    [Abstract] [Full Text] [Related]

  • 6. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
    Gelehrter TD, Sznycer-Laszuk R, Zeheb R, Cwikel BJ.
    Mol Endocrinol; 1987 Jan 01; 1(1):97-101. PubMed ID: 3137452
    [Abstract] [Full Text] [Related]

  • 7. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
    Lu XG, Wu XG, Xu XH, Gong XB, Zhou X, Xu GB, Zhu L, Zhao XY.
    J Zhejiang Univ Sci B; 2007 Aug 01; 8(8):570-4. PubMed ID: 17657859
    [Abstract] [Full Text] [Related]

  • 8. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporin A-treated patients.
    Buduneli N, Buduneli E, Ciotanar S, Atilla G, Lappin D, Kinane D.
    J Clin Periodontol; 2004 Jul 01; 31(7):556-61. PubMed ID: 15191592
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE, Roth RA.
    Toxicol Appl Pharmacol; 1993 Jul 01; 121(1):129-37. PubMed ID: 7687795
    [Abstract] [Full Text] [Related]

  • 10. Impairment of the blood-brain barrier: a potential surrogate delineating the determinants of cerebral bleeding caused by fibrinolytic drugs.
    Absher PM, Hendley E, Jaworski DM, Taatjes DJ, Sobel BE.
    Coron Artery Dis; 1999 Sep 01; 10(6):413-20. PubMed ID: 10474793
    [Abstract] [Full Text] [Related]

  • 11. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.
    Seth D, Hogg PJ, Gorrell MD, McCaughan GW, Haber PS.
    J Hepatol; 2008 Apr 01; 48(4):614-27. PubMed ID: 18289715
    [Abstract] [Full Text] [Related]

  • 12. Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately.
    van Giezen JJ, Chung-A-Hing JE, Vegter CB, Bouma BN, Jansen JW.
    Thromb Haemost; 1994 Dec 01; 72(6):887-92. PubMed ID: 7740459
    [Abstract] [Full Text] [Related]

  • 13. [Activation of fibrynolysis in children with chronic B or C hepatitis].
    Michalska K, Szaflarska-Popławska A, Dymek G, Kotschy M.
    Pol Merkur Lekarski; 2004 Oct 01; 17(100):316-20. PubMed ID: 15690691
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Oct 01; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 15. Circadian variation of plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition in aorta, heart, brain and lungs of the rat. Sex-related differences.
    Smokovitis A, Kokolis N, Tsandarliotou M.
    Thromb Res; 1993 Mar 01; 69(5):425-33. PubMed ID: 8497858
    [Abstract] [Full Text] [Related]

  • 16. Plasmin system regulation in an ovalbumin-induced rat model of asthma.
    Kucharewicz I, Mogielnicki A, Kasacka I, Buczko W, Bodzenta-Łukaszyk A.
    Int Arch Allergy Immunol; 2008 Mar 01; 147(3):190-6. PubMed ID: 18594148
    [Abstract] [Full Text] [Related]

  • 17. Distribution of tissue-type plasminogen activator (activity and antigen) in rat tissues.
    Padró T, van den Hoogen CM, Emeis JJ.
    Blood Coagul Fibrinolysis; 1990 Dec 01; 1(6):601-8. PubMed ID: 2133239
    [Abstract] [Full Text] [Related]

  • 18. Effect of orchidectomy on tissue plasminogen activator activity, plasminogen activator inhibition and plasmin inhibition.
    Kokolis NA.
    Haemostasis; 1990 Dec 01; 20(4):233-40. PubMed ID: 2147015
    [Abstract] [Full Text] [Related]

  • 19. Sex-related differences in plasminogen activator and plasminogen activator inhibiting activities in young and aged rats.
    Kojima T, Doi K, Kish M, Horiguchi Y.
    Res Commun Mol Pathol Pharmacol; 1999 Dec 01; 104(1):81-91. PubMed ID: 10604281
    [Abstract] [Full Text] [Related]

  • 20. Changes in plasminogen activator activity and plasmin inhibition in the pig during experimental hypovolaemia.
    Smokovitis A, Wagner M, Starlinger M, Opitz A, Binder BR.
    Thromb Haemost; 1985 Feb 18; 53(1):130-3. PubMed ID: 3158093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.